Image of methylene blue droplet
Image of submucosal cushion created by Eleview®
An FDA-cleared medical device1

See Eleview® in action

Watch an EMR of a 1-cm serrated lesion of the cecum. View transcript

Premixed with methylene blue, Eleview® is designed for easy and safe removal of polyps, adenomas, and other lesions.2

Image of time savings

Less time, less volume required3

Find out how Eleview® can add greater efficiency to your endoscopic procedures.1

Image of injection needle

Polypectomies, EMRs, and ESDs

View videos of polypectomies, EMRs, and ESDs performed using Eleview®.

Image of ampoules

Eleview® outlasts saline1

See how Eleview® creates reliable cushions that lift and last for up to 45 minutes.1

Image of GI medical staff

For nurses and surgical techs

Get guidelines and support for preparing and using Eleview®.

Images of Aries Pharmaceuticals, Inc. logo

Our commitment to GI

Discover how Aries is developing best-in-class products in endoscopy and GI disease treatment.

You are leaving to visit another Aries Pharmaceuticals, Inc. website.

Cancel Send Request


Eleview® submucosal injectable composition is intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers, or other gastrointestinal mucosal lesions, prior to excision with a snare or endoscopic device.


Patients with known sensitivity to any of the components contained in Eleview®.


  • The endoscopist injecting Eleview® must be experienced in the administration technique.
  • The safety of Eleview® has not been established in pregnant or lactating women, or in children under 18 years of age.
  • Eleview® is provided in single-use ampoules. Eleview® should not be reused after the first opening. Any emulsion not injected during the procedure should not be reused for another endoscopic procedure.
  • Do not use if the primary packaging (ampoule) or secondary packaging (aluminum pouch) is damaged.
  • Do not use if the twist-off cap is damaged.
  • Do not use if the emulsion is not clear, shows any signs of opalescence, or contains floating or precipitated visible particles.
  • The product compatibility with other substances has not been tested.


Rarely, local bleeding and/or inflammatory reaction could occur which may or may not be associated with Eleview®.


The administered dose of Eleview® should be determined based on the dimensions of the lesion to be removed. Inject into the submucosa the amount of Eleview® needed to form a submucosal cushion of optimal height and shape for the lesion to be removed. During the procedure do not exceed a total dose of 50 mL per patient, either in single or in multiple administrations.

Please see Instructions for Use for complete Important Safety Information.